Single provider of flu vaccines for Brazil’s public immunization program: 60 million doses in 2018, full capacity up to 140 million doses/year
Manufactures 90% of all animal-derived immunoglobulins distributed in Brazil
Tetravalent dengue vaccine: Butantan-MSD agreement recently signed
Successful R&D collaborations with major players as GSK, MSD and Sanofi.
Intellectual property: over 50 patent families
Located in São Paulo, Brazil, where 78% of the Brazilian pharma sales occur
Nós usamos cookies e outras tecnologias semelhantes em nossos sites para melhorar o desenvolvimento de conteúdo interessante para nossos visitantes. Ao utilizar nossos sites, você concorda com tal monitoramento.
